| Recruiting | Analysis of the Role of IgE Proteoforms in Health and Disease NCT07328178 | KU Leuven | — |
| Recruiting | Institutional Registry of Rare Diseases NCT06573723 | Hospital Italiano de Buenos Aires | — |
| Recruiting | Mastocytosis Registry (of Zurich) NCT06466889 | University of Zurich | — |
| Not Yet Recruiting | Study of Cellular Heterogeneity in Patients With Mastocytosis NCT06432556 | University Hospital, Toulouse | N/A |
| Unknown | Angioedema Biomarker Research Study NCT06210698 | Foundation For Rare Disease Research | — |
| Active Not Recruiting | (Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Sm NCT05186753 | Cogent Biosciences, Inc. | Phase 2 |
| Unknown | Hydroxychloroquine in Isolated Cutaneous Mastocytosis Patients or Indolent Systemic Mastocytosis With Associat NCT05084872 | University Hospital, Toulouse | Phase 2 / Phase 3 |
| Unknown | Assessment of Burden Disease in Patients With Mast Cell Disorders NCT04615663 | University Hospital, Toulouse | — |
| Recruiting | Relationship Between Circulating Sclerostin and Bone Lesions in Patients With Mastocytosis NCT06440148 | Medical University of Lublin | — |
| Completed | Mast Cell Activation Test in Allergic Disease NCT03406325 | Hong Kong Sanatorium & Hospital | — |
| Unknown | Mechanisms of Action of Photo(Chemo)Therapy in Skin Diseases NCT03340155 | Medical University of Graz | N/A |
| Completed | Mast Cell Connect: A Registry for Patients With Mastocytosis NCT02620254 | Blueprint Medicines Corporation | — |
| Completed | The Significance of Blood-tryptase and c-Kit Mutation in Insect Venom Immunotherapy NCT02503800 | Meir Medical Center | — |
| Withdrawn | Pregnancy and Medically Assisted Conception in Rare Diseases NCT02450396 | Assistance Publique - Hôpitaux de Paris | — |
| Completed | Treatment of Indolent Systemic Mastocytosis With PA101 NCT02478957 | Patara Pharma | Phase 2 |
| Recruiting | Myeloproliferative Neoplasms (MPNs) Patient Registry NCT02760238 | University Health Network, Toronto | — |
| Terminated | Cromoglicate in Mastocytosis NCT01701843 | LEO Pharma | Phase 2 |
| Completed | The Effect of Xolair ® (Omalizumab) in Mastocytosis Patients NCT01333293 | University of Zurich | Phase 2 / Phase 3 |
| Completed | A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies NCT01384513 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Phase 2 |
| Completed | Study on Mastocytosis for Rupatadine Treatment NCT01481909 | Marcus Maurer | Phase 2 / Phase 3 |
| Completed | Masitinib in Patients With Mastocytosis With Handicap and Bearing the D816V Mutation NCT01266369 | AB Science | Phase 2 |
| Completed | Dasatinib as Therapy for Myeloproliferative Disorders (MPDs) NCT00255346 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Efficacy of AB1010 in Patients With Systemic Indolent Mastocytosis NCT00831974 | AB Science | Phase 2 |
| Completed | Molecular Mechanisms and Diagnosis of Mastocytosis NCT00336076 | University of Michigan | — |
| Completed | Cause and Natural Course of Pediatric-Onset Mastocytosis NCT00050193 | National Institute of Allergy and Infectious Diseases (NIAID) | — |
| Completed | Blood Factors in Mastocytosis and Unexplained Anaphylaxis and Flushing NCT00047918 | National Institute of Allergy and Infectious Diseases (NIAID) | — |
| Recruiting | Study of Factors Regulating Mast Cell Proliferation NCT00044122 | National Institute of Allergy and Infectious Diseases (NIAID) | — |
| Completed | Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and NCT00038675 | M.D. Anderson Cancer Center | N/A |
| Completed | Stem Cell Transplantation to Treat Systemic Mastocytosis NCT00006413 | National Heart, Lung, and Blood Institute (NHLBI) | Phase 2 |
| Completed | Cytokine Production Patterns in Patients With Systemic Mastocytosis Compared With Atopic Dermatitis and Health NCT00001760 | National Institute of Allergy and Infectious Diseases (NIAID) | — |
| Completed | Study of Mast Cell Precursors NCT00001756 | National Institute of Allergy and Infectious Diseases (NIAID) | — |
| Terminated | Evaluation and Long-Term Follow-Up of Patients With Allergic and Inflammatory Disorders NCT00557895 | National Institute of Allergy and Infectious Diseases (NIAID) | — |
| Completed | Characteristics of Mast Cells in Mastocytosis NCT00001356 | National Institute of Allergy and Infectious Diseases (NIAID) | — |